TY  - JOUR
T1  - Sentinel lymph node biopsy in early melanoma: Comment on “what the surgeon should have said to my patient with thin malignant melanoma”
AU  - Linos E
Y1  - 2012/06/25
N1  - 10.1001/archinternmed.2012.1905
JO  - Archives of Internal Medicine
SP  - 907
EP  - 907
VL  - 172
IS  - 12
N2  - 
Sentinel node biopsy may be a useful prognostic tool for a subset of melanomas of intermediate stage.1 The Perspective by Benjamin and Froom,2 however, highlights the problems with its use in a different situation: a patient with an early stage IA melanoma, 0.5 mm in depth, without ulceration or a high mitotic rate. This patient has an excellent prognosis, with a 98% expected survival at 15 years and a greater than 97% chance of having clear lymph nodes.3- 4

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.1905
UR  - http://dx.doi.org/10.1001/archinternmed.2012.1905
ER  -